New hope for kids with tough leukemia: drug combo enters human testing
Disease control
Recruiting now
This early-stage trial is testing whether adding the drug talazoparib to standard chemotherapy is safe for children and young adults up to age 21 whose acute myeloid leukemia (AML) has returned or not responded to treatment. About 34 participants will receive different doses to f…
Phase: PHASE1 • Sponsor: Norman J. Lacayo • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC